FindTrial
Sign In

Study of genetic variations and activity of angiotensin-converting enzymes (Ace1 and Ace2) in Covid-19 patients

Study of genetic polymorphism and activity of angiotensin converting enzymes (Ace1 and Ace2) in Covid-19 patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-424x4r6
Enrollment
Unknown
Registered
2021-07-31
Start date
2020-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus Infections

Interventions

This observational study intends to perform a comparative genetic and biochemical analysis of blood samples from 1.761 COVID-19 patients already cured (symptomatic or asymptomatic) and uninfected indi
E05.318.308.980

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Hospital do Rim
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Healthy volunteers; volunteers who were infected with the coronavirus; volunteers who were not infected with coronavirus; both genders; at least 18 years of age.

Exclusion criteria

Exclusion criteria: Patients under 18 years of age.

Design outcomes

Primary

MeasureTime frame
Influence of polymorphisms and ACE1 or ACE2 activity on the degree of symptoms of COVID-19 patients.—

Secondary

MeasureTime frame
Secondary outcomes are not expected.—

Countries

Brazil

Contacts

Public ContactDulce Casarini
decasarini@gmail.com+5511992918512

Outcome results

None listed

Source: REBEC (via WHO ICTRP)